AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Mortality Rates of Myeloma Patients in the COVID Era
This chapter discusses the mortality rates of myeloma patients during the COVID-19 pandemic, highlighting the higher mortality rate compared to non-cancer patients. It explores factors such as age, gender, disease activity, renal impairment, and comorbidity that predict high mortality rates in myeloma patients. The chapter also examines the impact of COVID-19 on myeloma patients in different countries and emphasizes the importance of disease control and immune function in determining outcomes.